PD 535 40
Generic Name: quinapril
Pill imprint PD 535 40 has been identified as Accupril 40 mg.
Accupril is used in the treatment of high blood pressure; heart failure; diabetic kidney disease; left ventricular dysfunction and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Accupril 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Accupril Images
- Generic Name:
- quinapril
- Imprint:
-
PD 535
40 - Strength:
- 40 mg
- Color:
- Brown
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- candelilla wax
crospovidone
gelatin
lactose
magnesium carbonate
magnesium stearate
ferric oxide red
titanium dioxide
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Parke-Davis
- National Drug Code (NDC):
- 00071-0535
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-3445 | Physicians Total Care Inc (repackager) |
| 55289-0555 | PDRX Pharmaceuticals Inc (repackager) |
| 57866-4424 | Direct Dispensing Inc (repackager) |
| 63874-0058 | Altura Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.


